2020 ASCO Virtual Direct™ Highlights


 

2020 ASCO Highlights on HER2+ MBC: Incorporating New HER2 Targeted Agents - Neratinib, Pertuzumab & T-DM-1

220 views
August 26, 2020
0 Comments
Login to view comments. Click here to Login